Volume 36, Issue 6 1 pp. 1307-1313
Article

Combining Early Postoperative Parathyroid Hormone and Serum Calcium Levels Allows for an Efficacious Selective Post-thyroidectomy Supplementation Treatment

Marco Raffaelli

Marco Raffaelli

Division of General and Endocrine Surgery, Department of Surgery, Università Cattolica del Sacro Cuore, Rome, Italy

Search for more papers by this author
Carmela De Crea

Corresponding Author

Carmela De Crea

Division of General and Endocrine Surgery, Department of Surgery, Università Cattolica del Sacro Cuore, Rome, Italy

U.O. di Chirurgia Generale ed Endocrina, Istituto di Semeiotica Chirurgica, Università Cattolica del Sacro Cuore, L.go A. Gemelli 8, 00168 Rome, Italy

[email protected]Search for more papers by this author
Cinzia Carrozza

Cinzia Carrozza

Institute of Biochemistry, Università Cattolica del Sacro Cuore, Rome, Italy

Search for more papers by this author
Gerardo D’Amato

Gerardo D’Amato

Division of General and Endocrine Surgery, Department of Surgery, Università Cattolica del Sacro Cuore, Rome, Italy

Search for more papers by this author
Cecilia Zuppi

Cecilia Zuppi

Institute of Biochemistry, Università Cattolica del Sacro Cuore, Rome, Italy

Search for more papers by this author
Rocco Bellantone

Rocco Bellantone

Division of General and Endocrine Surgery, Department of Surgery, Università Cattolica del Sacro Cuore, Rome, Italy

Search for more papers by this author
Celestino P. Lombardi

Celestino P. Lombardi

Division of General and Endocrine Surgery, Department of Surgery, Università Cattolica del Sacro Cuore, Rome, Italy

Search for more papers by this author
First published: 16 March 2012
Citations: 53

Presented at the ISW 2011-IAES free paper session, Pacifico Yokohama, Japan, 28 August-1 September 2011

Abstract

Background

Optimal treatment protocol to prevent symptomatic hypocalcemia following total thyroidectomy is still matter of debate. We prospectively evaluated the efficacy of a selective supplementation protocol based on both early postoperative intact parathyroid hormone (iPTH) and serum calcium levels.

Methods

Two hundred thirty consecutive patients were divided in three different groups of treatment according to iPTH levels 4 h after total thyroidectomy (4 h-iPTH) and serum calcium levels in the first postoperative day (1PO-Ca): group A (4 h-iPTH > 10 pg/ml, 1PO-Ca ≥ 8.5 mg/dl), no treatment; group B (4 h-iPTH > 10 pg/ml, 1PO-Ca < 8.5 mg/dl), oral calcium (OC) 3 g per day; and group C (4 h-iPTH ≤ 10 pg/ml), OC 3 g + calcitriol (VD) 1 μg per day. Development of biochemical and/or symptomatic hypocalcemia was evaluated.

Results

Fifty-nine patients (25.6%) had subnormal 4 h-iPTH levels (≤10 pg/ml) (group C). Among patients with normal 4 h-iPTH levels, 25 (10.9%) had subnormal 1PO-Ca (<8.5 mg/dl) (group B). The remaining 146 patients (63.5%) had normal 4 h-iPTH and 1PO-Ca levels (group A). One patient in group A, 2 in group B, and 18 in group C developed biochemical hypocalcemia. Only one patient in group C experienced major symptoms. Treatment was discontinued within 1 month in all the patients in group B. At a mean follow-up of 303 days, five patients in group C were still under supplementation treatment.

Conclusion

The proposed supplementation protocol seems efficacious in preventing symptomatic hypocalcemia. It could allow a safe and early discharge of most patients, thus avoiding the constraints and the costs of routine supplementation.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.